Allied Nevada Gold Corp. (NYSEMKT: ANV) reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.09. The company had revenue of $85.50 million for the quarter, compared to the consensus estimate of $83.54 million. During the same quarter in the previous year, the company posted $0.10 earnings per share. The company’s revenue for the quarter was up 73.9% on a year-over-year basis. Analysts expect that Allied Nevada Gold Corp. will post $-0.34 EPS for the current fiscal year. Allied Nevada Gold Corp. (NYSEMKT: ANV) net profit margin is 0.60% and weekly performance is 20.52%. On last trading day company shares ended up $3.23. Analysts mean target price for the company is $3.29. Allied Nevada Gold Corp. (NYSEMKT: ANV) distance from 50-day simple moving average (SMA50) is -6.55%.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) was a big mover last session with its shares rising just over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares advanced 6.67% in last trading session and ended the day on $1.76. LXRX return on assets is -38.20%.
Shares of Doral Financial Corp. (NYSE:DRL) rose after the Supreme Court of Puerto Rico agreed to hear a suit filed by the bank holding company against the Commonwealth seeking to recover over $229 million in excess tax payments. Doral Financial Corp. (NYSE:DRL) shares moved up 21.38% in last trading session and was closed at $4.94, while trading in range of $4.20 – $5.13. Doral Financial Corp. (NYSE:DRL) year to date (YTD) performance is -68.45%.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) said it has seen 2 positive estimate revisions in the past one month, while its Zacks Consensus Estimate of a loss narrowed over the same timeframe, suggesting that more solid trading could be ahead for the company. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) ended the last trading day at $1.24. Company weekly volatility is calculated as 7.26% and price to cash ratio as 0.73. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) showed a positive weekly performance of 19.23%.
TASER International, Inc. (NASDAQ:TASR) announced that Bret Taylor will be joining its Board of Directors. Mr. Taylor was the co-creator of Google Maps, CEO of Friendfeed, CTO of Facebook, and is now CEO of Quip. TASER International, Inc. (NASDAQ:TASR) net profit margin is 12.80% and weekly performance is 9.85%. On last trading day company shares ended up $14.28. Analysts mean target price for the company is $17.50. TASER International, Inc. (NASDAQ:TASR) distance from 50-day simple moving average (SMA50) is -6.95%.